Secukinumab Injection

Secukinumab injection is a monoclonal antibody drug used to treat a variety of tumors and inflammatory diseases. Its main ingredient is secukinumab, which is mainly used to treat adult patients with moderate to severe plaque psoriasis who meet the indications of systemic treatment or phototherapy.
Because the number of lymphocytes and innate immune cells that secrete IL-17A and the level of IL-17A are increased in the blood of patients with psoriatic arthritis and ankylosing spondylitis. Secukinumab can reduce the levels of epidermal neutrophils and IL-17A in psoriasis plaques.

Secukinumab injection is a monoclonal antibody drug used to treat a variety of tumors and inflammatory diseases. Its main ingredient is secukinumab, which is mainly used to treat adult patients with moderate to severe plaque psoriasis who meet the indications of systemic treatment or phototherapy.
Because the number of lymphocytes and innate immune cells that secrete IL-17A and the level of IL-17A are increased in the blood of patients with psoriatic arthritis and ankylosing spondylitis. Secukinumab can reduce the levels of epidermal neutrophils and IL-17A in psoriasis plaques.